Harvard Bioscience (HBIO) Divestments (2013 - 2023)

Harvard Bioscience's (HBIO) quarterly Divestments came in at $512000.0 in Q1 2023, up 2944.44% on a QoQ basis from -$18000.0 in Q4 2019.

Harvard Bioscience (HBIO) Divestments (2013 - 2023) Analysis & Trends

Harvard Bioscience (HBIO) has 5 years of Divestments data on file, last reported at $512000.0 in Q1 2023.

On a quarterly basis, Divestments changed N/A year-over-year to $512000.0 in Q1 2023; TTM through Dec 2023 was $512000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $512000.0, changed N/A from the prior year.
Divestments for Q1 2023 stood at $512000.0, up from -$18000.0 in the prior quarter.
Over the last five years, Divestments for HBIO reached as high as $1.0 million in Q2 2019 and fell as low as -$18000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	-
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	-
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	-
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	-
10	Harvard Bioscience	28.05 Mn	20.96 Mn	12.24 Mn	-

Download Data